165 related articles for article (PubMed ID: 38454407)
1. PLA2G4A and ACHE modulate lipid profiles via glycerophospholipid metabolism in platinum-resistant gastric cancer.
Chen M; Zhang C; Li H; Zheng S; Li Y; Yuan M; Chen Y; Wu J; Sun Q
J Transl Med; 2024 Mar; 22(1):249. PubMed ID: 38454407
[TBL] [Abstract][Full Text] [Related]
2. Lipidomic studies revealing serological markers associated with the occurrence of retinopathy in type 2 diabetes.
He M; Hou G; Liu M; Peng Z; Guo H; Wang Y; Sui J; Liu H; Yin X; Zhang M; Chen Z; Rensen PCN; Lin L; Wang Y; Shi B
J Transl Med; 2024 May; 22(1):448. PubMed ID: 38741137
[TBL] [Abstract][Full Text] [Related]
3. Lipid metabolism analysis for peripheral blood in patients with alcohol
Yan Y; Yu Y; Liu J; Zhao H; Wang J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Jul; 47(7):872-880. PubMed ID: 36039583
[TBL] [Abstract][Full Text] [Related]
4. Serum Metabolic Profiling Analysis of Chronic Gastritis and Gastric Cancer by Untargeted Metabolomics.
Yu L; Lai Q; Feng Q; Li Y; Feng J; Xu B
Front Oncol; 2021; 11():636917. PubMed ID: 33777793
[TBL] [Abstract][Full Text] [Related]
5. Lipidomic profiles in serum and urine in children with steroid sensitive nephrotic syndrome.
Hu L; Peng Z; Bai G; Fu H; Tan DJ; Wang J; Li W; Cao Z; Huang G; Liu F; Xie Y; Lin L; Sun J; Gao L; Chen Y; Zhu R; Mao J
Clin Chim Acta; 2024 Mar; 555():117804. PubMed ID: 38316288
[TBL] [Abstract][Full Text] [Related]
6. Targeted metabolomics analysis for serum Helicobacter pylori-positive based on liquid chromatography-tandem mass spectrometry.
Wang J; Shan J; Zhang Y; Shi Y; Lu D; Wu Y; Guo XP; Liu H; Wang J; Hu N
Biomed Chromatogr; 2023 Jun; 37(6):e5622. PubMed ID: 36898359
[TBL] [Abstract][Full Text] [Related]
7. Untargeted lipidomic analysis and network pharmacology for parthenolide treated papillary thyroid carcinoma cells.
Huang LT; Li TJ; Li ML; Luo HY; Wang YB; Wang JH
BMC Complement Med Ther; 2023 Apr; 23(1):130. PubMed ID: 37095470
[TBL] [Abstract][Full Text] [Related]
8. [Nontargeted lipidomic analysis of sera from sepsis patients based on ultra-high performance liquid chromatography-mass spectrometry/mass spectrometry].
Wang S; Liang J; Shi H; Xia Y; Li J; Wu W; Wang H; Wu W
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Apr; 34(4):346-351. PubMed ID: 35692196
[TBL] [Abstract][Full Text] [Related]
9. The Changes of Lipidomic Profiles Reveal Therapeutic Effects of Exenatide in Patients With Type 2 Diabetes.
Zhang L; Hu Y; An Y; Wang Q; Liu J; Wang G
Front Endocrinol (Lausanne); 2022; 13():677202. PubMed ID: 35432194
[TBL] [Abstract][Full Text] [Related]
10. Serum lipidomic profiling by UHPLC-MS/MS may be able to detect early-stage endometrial cancer.
Cheng F; Fan W; Gui L; Liu Y; Ling Y; Huang R; Wen Z; Chen Y
Anal Bioanal Chem; 2023 Apr; 415(10):1841-1854. PubMed ID: 36799979
[TBL] [Abstract][Full Text] [Related]
11. [Plasma metabolomics in a deep vein thrombosis rat model based on ultra-high performance liquid chromatography-electrostatic field orbitrap high resolution mass spectrometry].
Gu Y; Zang P; Li J; Yan Y; Wang J
Se Pu; 2022 Aug; 40(8):736-745. PubMed ID: 35903841
[TBL] [Abstract][Full Text] [Related]
12. Emodin Improves Glucose and Lipid Metabolism Disorders in Obese Mice
Cheng L; Zhang S; Shang F; Ning Y; Huang Z; He R; Sun J; Dong S
Front Endocrinol (Lausanne); 2021; 12():618037. PubMed ID: 34040579
[TBL] [Abstract][Full Text] [Related]
13. Identifying potential biomarkers and therapeutic targets for dogs with sepsis using metabolomics and lipidomics analyses.
Montague B; Summers A; Bhawal R; Anderson ET; Kraus-Malett S; Zhang S; Goggs R
PLoS One; 2022; 17(7):e0271137. PubMed ID: 35802586
[TBL] [Abstract][Full Text] [Related]
14. Reduced group IVA phospholipase A2 expression is associated with unfavorable outcome for patients with gastric cancer.
Zhang X; Wu Q; Gan L; Yu GZ; Wang R; Wang ZS; Wang JJ; Wang X
Med Oncol; 2013 Mar; 30(1):454. PubMed ID: 23307260
[TBL] [Abstract][Full Text] [Related]
15. Lipid metabolism and identification of biomarkers in asthma by lipidomic analysis.
Jiang T; Dai L; Li P; Zhao J; Wang X; An L; Liu M; Wu S; Wang Y; Peng Y; Sun D; Zheng C; Wang T; Wen X; Cheng Z
Biochim Biophys Acta Mol Cell Biol Lipids; 2021 Feb; 1866(2):158853. PubMed ID: 33160078
[TBL] [Abstract][Full Text] [Related]
16. Identification of lipidomic profiles associated with drug-resistant prostate cancer cells.
Ingram LM; Finnerty MC; Mansoura M; Chou CW; Cummings BS
Lipids Health Dis; 2021 Feb; 20(1):15. PubMed ID: 33596934
[TBL] [Abstract][Full Text] [Related]
17. Lipidomics based on UHPLC/Q-TOF-MS to characterize lipid metabolic profiling in patients with newly diagnosed type 2 diabetes mellitus with dyslipidemia.
Zhong X; Xiao C; Wang R; Deng Y; Du T; Li W; Zhong Y; Tan Y
Heliyon; 2024 Feb; 10(4):e26326. PubMed ID: 38404868
[TBL] [Abstract][Full Text] [Related]
18. Combined untargeted and targeted lipidomics approaches reveal potential biomarkers in type 2 diabetes mellitus cynomolgus monkeys.
Tian CY; Yang QH; Lv HZ; Yue F; Zhou FF
J Med Primatol; 2024 Feb; 53(1):e12688. PubMed ID: 38083989
[TBL] [Abstract][Full Text] [Related]
19. Group III phospholipase A2 downregulation attenuated survival and metastasis in ovarian cancer and promotes chemo-sensitization.
Ray U; Roy D; Jin L; Thirusangu P; Staub J; Xiao Y; Kalogera E; Wahner Hendrickson AE; Cullen GD; Goergen K; Oberg AL; Shridhar V
J Exp Clin Cancer Res; 2021 Jun; 40(1):182. PubMed ID: 34082797
[TBL] [Abstract][Full Text] [Related]
20. The lipidomic profile of the tumoral periprostatic adipose tissue reveals alterations in tumor cell's metabolic crosstalk.
Altuna-Coy A; Ruiz-Plazas X; Sánchez-Martin S; Ascaso-Til H; Prados-Saavedra M; Alves-Santiago M; Bernal-Escoté X; Segarra-Tomás J; R Chacón M
BMC Med; 2022 Aug; 20(1):255. PubMed ID: 35978404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
